By Caroline Valetkevitch NEW YORK (Reuters) – U.S. healthcare companies are winning higher profit forecasts, bucking a wider trend on Wall Street, as pricey new biotech drugs hit the market and insurance enrollment rises under the Affordable Care Act. Analysts’ profit…
Source:U.S. healthcare profit outlook brightens on Obamacare, drug prices
No comments:
Post a Comment